Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,757 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.
Crane CH, Varadhachary GR, Yordy JS, Staerkel GA, Javle MM, Safran H, Haque W, Hobbs BD, Krishnan S, Fleming JB, Das P, Lee JE, Abbruzzese JL, Wolff RA. Crane CH, et al. Among authors: krishnan s. J Clin Oncol. 2011 Aug 1;29(22):3037-43. doi: 10.1200/JCO.2010.33.8038. Epub 2011 Jun 27. J Clin Oncol. 2011. PMID: 21709185 Free PMC article. Clinical Trial.
Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.
Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH. Das P, et al. Among authors: krishnan s. Am J Clin Oncol. 2006 Jun;29(3):219-24. doi: 10.1097/01.coc.0000214930.78200.4a. Am J Clin Oncol. 2006. PMID: 16755173
Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH. Krishnan S, et al. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):762-71. doi: 10.1016/j.ijrobp.2006.05.063. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011451 Clinical Trial.
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis.
Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Janjan NA, Crane CH. Das P, et al. Among authors: krishnan s. Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1378-83. doi: 10.1016/j.ijrobp.2006.07.1374. Epub 2006 Oct 23. Int J Radiat Oncol Biol Phys. 2006. PMID: 17056196
Predictors and patterns of recurrence after definitive chemoradiation for anal cancer.
Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH. Das P, et al. Among authors: krishnan s. Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):794-800. doi: 10.1016/j.ijrobp.2006.12.052. Epub 2007 Mar 26. Int J Radiat Oncol Biol Phys. 2007. PMID: 17379452 Clinical Trial.
2,757 results